Skip to main content
Investors
Media
open in a new window
Contact Us
open in a new window
|
Search
open in a new window
Company
Science & Medicine
Patients
Responsibility
Careers
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
Stock Information
Stock Quote & Chart
Historical Stock Quote
Analyst Coverage
Investor FAQs
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
Stock Information
Stock Quote & Chart
Historical Stock Quote
Analyst Coverage
Investor FAQs
Close
Close
Investors
Company
Product
Research & Development
Patients
Partnerships
Careers
Close
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
December 22, 2016
Ironwood and Allergan Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2) for Abdominal Pain in Non-Constipation Subtypes of IBS
Download
PDF format download (opens in new window)
December 22, 2016
Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 (CR1) in IBS-C
Download
PDF format download (opens in new window)
December 19, 2016
Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in Japan for the Treatment of Adults with IBS-C
Download
PDF format download (opens in new window)
November 13, 2016
Ironwood Highlights ZURAMPIC® (lesinurad) Phase III Extension Study Data at the American College of Rheumatology 2016 Annual Meeting
Download
PDF format download (opens in new window)
November 10, 2016
Ironwood Pharmaceuticals to Present at Stifel 2016 Healthcare Conference
Download
PDF format download (opens in new window)
November 3, 2016
Ironwood Pharmaceuticals Provides Third Quarter 2016 Investor Update
Download
PDF format download (opens in new window)
November 1, 2016
Ironwood Pharmaceuticals to Present at Credit Suisse 25th Annual Healthcare Conference
Download
PDF format download (opens in new window)
October 25, 2016
Ironwood Highlights Breadth of Gout Research with Presentations at the American College of Rheumatology 2016 Annual Meeting
Download
PDF format download (opens in new window)
October 20, 2016
Ironwood Pharmaceuticals to Host Third Quarter 2016 Investor Update Call
Download
PDF format download (opens in new window)
October 3, 2016
Nine in Ten Physicians Agree Target Goal for Gout Is Imperative, Yet Half of Patients Fail to Reach It, New Survey Shows
Download
PDF format download (opens in new window)
October 3, 2016
Ironwood Announces U.S. Availability of ZURAMPIC® (lesinurad) 200 mg Tablets for Patients with Uncontrolled Gout
Download
PDF format download (opens in new window)
September 26, 2016
Ironwood Closes $150 Million Debt Refinancing
Download
PDF format download (opens in new window)
September 7, 2016
Ironwood Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Download
PDF format download (opens in new window)
September 1, 2016
Ironwood Pharmaceuticals to Present at Wells Fargo 2016 Healthcare Conference
Download
PDF format download (opens in new window)
August 4, 2016
Ironwood Pharmaceuticals Provides Second Quarter 2016 Investor Update
Download
PDF format download (opens in new window)
July 21, 2016
Ironwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call
Download
PDF format download (opens in new window)
June 9, 2016
Ironwood and Allergan Announce Supplemental New Drug Application for 72 mcg Linaclotide in Chronic Idiopathic Constipation Has Been Accepted for FDA Review
Download
PDF format download (opens in new window)
June 6, 2016
Ironwood Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference
Download
PDF format download (opens in new window)
June 3, 2016
Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
Download
PDF format download (opens in new window)
June 1, 2016
Ironwood Pharmaceuticals to Present at Goldman Sachs 37th Annual Global Healthcare Conference
Download
PDF format download (opens in new window)
May 18, 2016
Ironwood Pharmaceuticals to Present at 2016 UBS Global Healthcare Conference
Download
PDF format download (opens in new window)
May 17, 2016
Ironwood Pharmaceuticals to Present Linaclotide Data at Digestive Disease Week® 2016
Download
PDF format download (opens in new window)
May 9, 2016
Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update
Download
PDF format download (opens in new window)
May 3, 2016
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2016 Health Care Conference
Download
PDF format download (opens in new window)
April 26, 2016
Ironwood Pharmaceuticals Enters into U.S. Licensing Agreement with AstraZeneca for Lesinurad
Download
PDF format download (opens in new window)
April 25, 2016
Ironwood Pharmaceuticals to Host First Quarter 2016 Investor Update Call
Download
PDF format download (opens in new window)
April 7, 2016
Ironwood Pharmaceuticals Appoints Andrew Dreyfus to Board of Directors
Download
PDF format download (opens in new window)
April 5, 2016
Ironwood Pharmaceuticals Reports Top-Line Data from Exploratory Phase IIa Study of IW-9179 in Diabetic Gastroparesis
Download
PDF format download (opens in new window)
March 30, 2016
Ironwood Pharmaceuticals to Present Clinical and Preclinical Data on sGC Stimulators at Upcoming Scientific Conferences
Download
PDF format download (opens in new window)
March 23, 2016
Ironwood Pharmaceuticals Initiates Phase IIb Clinical Trial of IW-3718 in Refractory Gastroesophageal Reflux Disease
Download
PDF format download (opens in new window)
March 9, 2016
Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Download
PDF format download (opens in new window)
March 1, 2016
Ironwood Pharmaceuticals to Present at Cowen and Company 36th Annual Health Care Conference
Download
PDF format download (opens in new window)
February 29, 2016
Video Alert: Updated 2016 Direct-to-Consumer Awareness Campaign Available for LINZESS® (linaclotide)
Download
PDF format download (opens in new window)
February 24, 2016
Ironwood Pharmaceuticals Announces Filing by Astellas of New Drug Application in Japan with Linaclotide for the Treatment of Adults with IBS-C
Download
PDF format download (opens in new window)
February 18, 2016
Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2015 Investor Update
Download
PDF format download (opens in new window)
February 18, 2016
Ironwood Pharmaceuticals Progresses Vascular and Fibrotic Disease Platform with Positive Top-Line Phase Ia Data on Soluble Guanylate Cyclase Stimulator IW-1701
Download
PDF format download (opens in new window)
February 17, 2016
Ironwood Pharmaceuticals to Present at 2016 RBC Capital Markets Global Healthcare Conference
Download
PDF format download (opens in new window)
February 4, 2016
Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2015 Investor Update Call
Download
PDF format download (opens in new window)
January 11, 2016
Ironwood Pharmaceuticals Details Strategy to Build Top-Performing Commercial Biotechnology Company
Download
PDF format download (opens in new window)
January 4, 2016
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)